Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | thymidylate synthase | 0.0109 | 0 | 0.5 |
Mycobacterium ulcerans | thymidylate synthase | 0.0109 | 0 | 0.5 |
Leishmania major | thymidine kinase, putative | 0.0796 | 0.628 | 1 |
Echinococcus granulosus | thymidylate synthase | 0.0109 | 0 | 0.5 |
Trypanosoma cruzi | thymidine kinase, putative | 0.0796 | 0.628 | 1 |
Trichomonas vaginalis | thymidine kinase, putative | 0.0796 | 0.628 | 0.5 |
Brugia malayi | thymidylate synthase | 0.0109 | 0 | 0.5 |
Mycobacterium leprae | PROBABLE THYMIDYLATE SYNTHASE THYA (TS) (TSASE) | 0.0109 | 0 | 0.5 |
Trypanosoma cruzi | thymidine kinase, putative | 0.0796 | 0.628 | 1 |
Trichomonas vaginalis | thymidine kinase, putative | 0.0796 | 0.628 | 0.5 |
Entamoeba histolytica | thymidine kinase, putative | 0.0796 | 0.628 | 0.5 |
Toxoplasma gondii | bifunctional dihydrofolate reductase-thymidylate synthase | 0.0154 | 0.0407 | 0.5 |
Echinococcus multilocularis | thymidylate synthase | 0.0109 | 0 | 0.5 |
Schistosoma mansoni | bifunctional dihydrofolate reductase-thymidylate synthase | 0.0109 | 0 | 0.5 |
Onchocerca volvulus | 0.0109 | 0 | 0.5 | |
Trypanosoma brucei | thymidine kinase | 0.0796 | 0.628 | 1 |
Plasmodium falciparum | bifunctional dihydrofolate reductase-thymidylate synthase | 0.0154 | 0.0407 | 0.5 |
Plasmodium vivax | bifunctional dihydrofolate reductase-thymidylate synthase, putative | 0.0154 | 0.0407 | 0.5 |
Mycobacterium tuberculosis | Probable thymidylate synthase ThyA (ts) (TSASE) | 0.0109 | 0 | 0.5 |
Trichomonas vaginalis | thymidine kinase, putative | 0.0796 | 0.628 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
C50 (binding) | = 0.11 nM | Inhibitory concentration against ethidium bromide binding to DNA | ChEMBL. | 4067986 |
C50 (binding) | = 0.14 nM | Inhibitory concentration against ethidium bromide binding to DNA | ChEMBL. | 4067986 |
ID50 (functional) | = 13 nM | In vitro inhibitory dose that reduces L1210 cell line by 50% when added for a period of 70h | ChEMBL. | 4067986 |
ID50 (functional) | = 13 nM | In vitro inhibitory dose that reduces L1210 cell line by 50% when added for a period of 70h | ChEMBL. | 4067986 |
ILS (functional) | = 46 % | The % increase in lifespan of treated animals over that of control group of animals injected with tumor alone | ChEMBL. | 4067986 |
ILS (functional) | = 46 % | The % increase in lifespan of treated animals over that of control group of animals injected with tumor alone | ChEMBL. | 4067986 |
OD (functional) | = 20 mg kg-1 | Highest nontoxic optimal dose administered intraperitoneally after inoculation of P388 leukemia cells | ChEMBL. | 4067986 |
OD (functional) | = 20 mg kg-1 | Highest nontoxic optimal dose administered intraperitoneally after inoculation of P388 leukemia cells | ChEMBL. | 4067986 |
Rm | = -0.3 | Lipophilicity (Rm) | ChEMBL. | 4067986 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.